Home Menu

Site Navigation



NeuroTalk Support Groups > > >

Teriflunomide

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 10-20-2008, 07:52 PM #1
SallyC's Avatar
SallyC SallyC is offline
In Remembrance
  
Join Date: Sep 2006
Location: SW Ohio
Posts: 17,844
15 yr Member
SallyC SallyC is offline
In Remembrance
SallyC's Avatar
 
Join Date: Sep 2006
Location: SW Ohio
Posts: 17,844
15 yr Member
Default Teriflunomide
Has anyone heard anything about this Trial of an Oral MS Med???

My DD has applied to enter this study.

She has been having an attack, for the last month or so........just telling Mom about it now , because she didn't want to worry me.. What! Me Worry! Nah!

Let me know what you know, if anything...or, what you think of it's potential...Kaaaaa?

http://www.nationalmssociety.org/new...x.aspx?nid=248
__________________
~Love, Sally
.





"The best way out is always through". Robert Frost



~If The World Didn't Suck, We Would All Fall Off~
SallyC is offline   Reply With QuoteReply With Quote
 

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Teriflunomide: results of an open-label 144-week extension study wannabe Multiple Sclerosis 0 10-02-2006 05:14 PM


All times are GMT -5. The time now is 02:02 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home